Jury Mulls Punitives Against Merck in Wake of $4.5M Vioxx Verdict

The punitive damages phase of the New Jersey Vioxx trial continued Monday, when the jury that last week found Merck & Co. liable for $4.5 million for not properly warning of the drug's dangers began deliberation over whether the company should pay additional damages. Jurors are deciding whether Merck concealed information with "willful and wanton" disregard for others. The maximum punitive damages allowable under state law are five times the compensatory damages, or $22.5 million.

This article requires premium access

This article requires premium access to Law.com. Please sign in or subscribe to read the full text.